820092
Last Update Posted: 2013-07-30
Recruiting has ended
All Genders accepted | 20 Years-45 Years |
38 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Xerecept Intravenous Dose Escalation in Japanese and Caucasian Volunteers
- To investigate the safety and tolerability of Xerecept during and following a 24-hour intravenous administration to healthy Japanese to healthy Japanese and Caucasian subjects
- To compare the PK profile of hCRF during and following a 24-hour intravenous Xerecept administration between healthy Japanese and Caucasian subjects
none needed
Eligibility
Relevant conditions:
Edema
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov